These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs. Agrawal S; Marquet J; Delfau-Larue MH; Copie-Bergman C; Jouault H; Reyes F; Bensussan A; Farcet JP J Clin Invest; 1998 Nov; 102(9):1715-23. PubMed ID: 9802885 [TBL] [Abstract][Full Text] [Related]
49. Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules. Kiessling R; Kono K; Petersson M; Wasserman K Springer Semin Immunopathol; 1996; 18(2):227-42. PubMed ID: 8908702 [No Abstract] [Full Text] [Related]
50. IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cells. Zier KS; Gansbacher B J Mol Med (Berl); 1996 Mar; 74(3):127-34. PubMed ID: 8846162 [TBL] [Abstract][Full Text] [Related]
51. Long-term inositol phosphate release, but not tyrosine kinase activity, correlates with IL-2 secretion and NF-AT induction in anti-CD3-activated peripheral human T lymphocytes. Bryan RG; Li Y; Totten RK; Van M; Tan TH; Rich RR Cell Immunol; 1994 Aug; 157(1):158-69. PubMed ID: 8039243 [TBL] [Abstract][Full Text] [Related]
52. Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NFkappaB suppression. Ng CS; Novick AC; Tannenbaum CS; Bukowski RM; Finke JH Urology; 2002 Jan; 59(1):9-14. PubMed ID: 11796271 [No Abstract] [Full Text] [Related]
53. T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report. Li X; Liu J; Park JK; Hamilton TA; Rayman P; Klein E; Edinger M; Tubbs R; Bukowski R; Finke J Cancer Res; 1994 Oct; 54(20):5424-9. PubMed ID: 7923175 [TBL] [Abstract][Full Text] [Related]
54. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy. Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963 [TBL] [Abstract][Full Text] [Related]
55. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209 [TBL] [Abstract][Full Text] [Related]
56. Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. Ghosh P; Sica A; Young HA; Ye J; Franco JL; Wiltrout RH; Longo DL; Rice NR; Komschlies KL Cancer Res; 1994 Jun; 54(11):2969-72. PubMed ID: 8187083 [TBL] [Abstract][Full Text] [Related]